Cargando…
Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells
Objective This study aims to explore the potential anti-cancer properties of boric acid (BA) in human endometrial cancer Ishikawa cells by assessing its influence on cell viability, apoptosis, oxidative stress, and inflammatory responses. Methods The impact of BA at concentrations ranging from 2.5 t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531031/ https://www.ncbi.nlm.nih.gov/pubmed/37772231 http://dx.doi.org/10.7759/cureus.44277 |
_version_ | 1785111625420767232 |
---|---|
author | Çakır Gündoğdu, Ayşe Arı, Neziha Senem Höbel, Asiye Şenol, Gülnihal Eldiven, Ömer Kar, Fatih |
author_facet | Çakır Gündoğdu, Ayşe Arı, Neziha Senem Höbel, Asiye Şenol, Gülnihal Eldiven, Ömer Kar, Fatih |
author_sort | Çakır Gündoğdu, Ayşe |
collection | PubMed |
description | Objective This study aims to explore the potential anti-cancer properties of boric acid (BA) in human endometrial cancer Ishikawa cells by assessing its influence on cell viability, apoptosis, oxidative stress, and inflammatory responses. Methods The impact of BA at concentrations ranging from 2.5 to 100 mM on cell viability was assessed in Ishikawa cells and normal fibroblast L929 cells (used as the control) through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Spectrophotometric measurements were performed to determine the total oxidant status (TOS) and total antioxidant status (TAS) in BA-treated cells, and the oxidative stress index (OSI) was calculated. The enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of cytochrome c and caspase 3, both of which are constituents of the extrinsic apoptotic pathway. Furthermore, changes in the concentrations of pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β) in the cells were analyzed using ELISA and immunofluorescence staining. Results The exposure of Ishikawa cells to BA for 24 hours led to a dose-dependent decline in cell viability, with an IC(50) value of 40 mM. BA dose-dependently increased cytochrome c and caspase 3 levels in cancer cells. In Ishikawa cells, BA treatment led to a significant elevation in OSI. Moreover, the concentrations of TNF-α and IL-1β exhibited a dose-dependent decrease in BA-treated cells. On the other hand, in L929 cells, BA decreased OSI in a dose-dependent manner but did not change TNF-α and IL-1β levels. Concentrations up to 80 mM had no effect on cell viability and apoptosis, but BA at 80 mM concentration decreased viability and increased cytochrome c and caspase 3 levels in L929 cells. Conclusion BA inhibited cell viability, triggered apoptosis, induced oxidative stress, and suppressed inflammatory responses in endometrial cancer cells. Notably, at its IC(50) concentration, BA had no cytotoxic effect on normal fibroblasts. Given its favorable properties, BA may provide a valuable therapeutic option to impede the development and progression of endometrial cancer. |
format | Online Article Text |
id | pubmed-10531031 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-105310312023-09-28 Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells Çakır Gündoğdu, Ayşe Arı, Neziha Senem Höbel, Asiye Şenol, Gülnihal Eldiven, Ömer Kar, Fatih Cureus Oncology Objective This study aims to explore the potential anti-cancer properties of boric acid (BA) in human endometrial cancer Ishikawa cells by assessing its influence on cell viability, apoptosis, oxidative stress, and inflammatory responses. Methods The impact of BA at concentrations ranging from 2.5 to 100 mM on cell viability was assessed in Ishikawa cells and normal fibroblast L929 cells (used as the control) through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Spectrophotometric measurements were performed to determine the total oxidant status (TOS) and total antioxidant status (TAS) in BA-treated cells, and the oxidative stress index (OSI) was calculated. The enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of cytochrome c and caspase 3, both of which are constituents of the extrinsic apoptotic pathway. Furthermore, changes in the concentrations of pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β) in the cells were analyzed using ELISA and immunofluorescence staining. Results The exposure of Ishikawa cells to BA for 24 hours led to a dose-dependent decline in cell viability, with an IC(50) value of 40 mM. BA dose-dependently increased cytochrome c and caspase 3 levels in cancer cells. In Ishikawa cells, BA treatment led to a significant elevation in OSI. Moreover, the concentrations of TNF-α and IL-1β exhibited a dose-dependent decrease in BA-treated cells. On the other hand, in L929 cells, BA decreased OSI in a dose-dependent manner but did not change TNF-α and IL-1β levels. Concentrations up to 80 mM had no effect on cell viability and apoptosis, but BA at 80 mM concentration decreased viability and increased cytochrome c and caspase 3 levels in L929 cells. Conclusion BA inhibited cell viability, triggered apoptosis, induced oxidative stress, and suppressed inflammatory responses in endometrial cancer cells. Notably, at its IC(50) concentration, BA had no cytotoxic effect on normal fibroblasts. Given its favorable properties, BA may provide a valuable therapeutic option to impede the development and progression of endometrial cancer. Cureus 2023-08-28 /pmc/articles/PMC10531031/ /pubmed/37772231 http://dx.doi.org/10.7759/cureus.44277 Text en Copyright © 2023, Çakır Gündoğdu et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Oncology Çakır Gündoğdu, Ayşe Arı, Neziha Senem Höbel, Asiye Şenol, Gülnihal Eldiven, Ömer Kar, Fatih Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells |
title | Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells |
title_full | Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells |
title_fullStr | Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells |
title_full_unstemmed | Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells |
title_short | Boric Acid Exhibits Anticancer Properties in Human Endometrial Cancer Ishikawa Cells |
title_sort | boric acid exhibits anticancer properties in human endometrial cancer ishikawa cells |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531031/ https://www.ncbi.nlm.nih.gov/pubmed/37772231 http://dx.doi.org/10.7759/cureus.44277 |
work_keys_str_mv | AT cakırgundogduayse boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells AT arınezihasenem boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells AT hobelasiye boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells AT senolgulnihal boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells AT eldivenomer boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells AT karfatih boricacidexhibitsanticancerpropertiesinhumanendometrialcancerishikawacells |